Adult-onset Still's disease classification

Jump to navigation Jump to search


Template:Adult-onset Still's disease Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Classification

Classification based on clinical presentation

Adult-onset Stiil's disease (AOSD) may be classified based on the predominant clinical picture with which the patient presents. The following are the sub-types:[1][2]

  • ASOD with pre-dominant systemic symptoms
  • ASOD with pre-dominant arthritis
Adult-onset Still's disease sub-types Systemic sub-type Distinguishing features
Pre-dominant cellular mechanism Cytokine profile Clinical presentation Laboratory findings Response to treatment Miscellaneous
  • Natural killer (NK) cell dysfunction (marked deficiency)
  • CD8 type (cytotoxic) T cell dysfunction (marked deficiency)
  • Neutrophil, monocyte and macrophage activation
  • Interleukin 1 beta
  • Interleukin 18
  • Interferon alpha and beta
  • Interleukin 4
  • Arhtraligia
  • Myalgia
  • Hepatitis
  • Spleenomegaly
  • Spiking fever (evening spike)
  • Orbital inflammation
  • Cardiac dysfunction
  • Pulmonary dysfucntion
  • Weight loss
  • Sore throat
  • Lymphadenopathy
  • Thrombocytopenia
  • Hyperferritinemia
  • Strong response to interleukin-1 inhibitors
  • Weak response to interleukin 18 inhibitors and interferon gamma inhibitors
  • Upregulation of genes involved in granulocyte formation
Arthritis sub-type
  • Natural killer (NK) cell dysfunction (deficiency)
  • CD8 type (cytotoxic) T cell dysfunction (deficiency)
  • Neutrophil, monocyte and macrophage activation
  • Interleukin 17
  • Interleukin 23
  • Interleukin 6
  • Tumor necrosis factor alpha (TNF-alpha)
  • Involvement of wrist, ankle, elbow joints, proximal interphalyngeal joints (PIP)
  • Arthralgia
  • Myalgia
  • Spiking fever
  • Salmon-colored maculopapular rash
  • Less common systemic and organ involvement
  • Thrombocytosis
  • Arthritis
  • Strong response to interleukin 6 inhibitors
  • Good response to TNF-alpha inhibitors
  • Weak reponse to interleukin 17 inhibitors

References

  1. Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A, Grom AA (2005). "Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome". Arthritis Res. Ther. 7 (1): R30–7. doi:10.1186/ar1453. PMC 1064882. PMID 15642140.
  2. Lee SJ, Cho YN, Kim TJ, Park SC, Park DJ, Jin HM, Lee SS, Kee SJ, Kim N, Yoo DH, Park YW (September 2012). "Natural killer T cell deficiency in active adult-onset Still's Disease: correlation of deficiency of natural killer T cells with dysfunction of natural killer cells". Arthritis Rheum. 64 (9): 2868–77. doi:10.1002/art.34514. PMID 22605480.